Pressure BioSciences, Inc.

349 articles about Pressure BioSciences, Inc.

• Pressure BioSciences Awarded Three Additional Patents for Revolutionary Ultra Shear Technology Platform

  5/13/2021

  Unique Commercial-Scale Capabilities for Highest-Quality Nanoemulsions of Oils in Water Enabled by PBI's UST Platform, Addressing Multiple Billion Dollar Opportunities in Diverse Markets Worldwide

• Pressure BioSciences, Inc. to Discuss Fourth Quarter and Fiscal Year 2020 Financial Results and Provide Business Update

  4/19/2021

  Pressure BioSciences, Inc. (OTCQB: PBIO) today announced that the Company will host a teleconference to discuss its Fourth Quarter and Fiscal Year 2020 financial results and to provide a business update. Anyone interested may listen to the teleconference either live (by telephone) or through a replay

• Pressure BioSciences Finalizes Plan to Acquire Global Eco-Friendly Agrochemical Supplier

  4/14/2021

  Company Expects Acquisition to be Accretive with Sustained Profitable Revenue Growth, Leveraging Market-Changing Synergy from PBIs Ultra Shear Technology Nanoemulsions Platform

• Transformative Impact for Food Industry Consortium Formed by Pressure BioSciences and The Ohio State University Discussed in Showcase Video from Emerging Technology Insider

  3/4/2021

  Interview of PBIO CEO Ric Schumacher Focuses on Potential Impact of Company's Innovative UST Platform for Major Advances in Food Safety, Clean Label, Nutrition, and Long-Term Room Temperature Stability

• Pressure BioSciences and The Ohio State University Announce Food Industry Consortium to Advance Commercialization of PBI's Ultra Shear Technology

  2/24/2021

  Academia-Industry Partnership to Support Improvements in UST Applications and Allow Global Food Companies Access to UST for Preparation of Safer, More Nutritious Liquid Foods and Beverages   [24-February-2021]   SOUTH EASTON, Mass. , Feb. 24, 2021 /PRNewswire/ --Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" or the "Company"), a leader in the development and sale of broa

• Pressure BioSciences Plans to Acquire Assets of Global Eco-Friendly Agrochemical Supplier

  2/8/2021

  PBI's Ultra Shear Technology for Nanoemulsion Processing Targets New Generation of High Performance, "Green" Agrochemicals for Worldwide Distribution into Food Production Markets

• Pressure BioSciences Ultra Shear Technology Nanoemulsions Platform Targets Revolution in Effectiveness of Therapeutics via Improved Drug Delivery and Dosing Safety

  1/20/2021

  Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" or the "Company"), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and platform technology services to the worldwide biotechnology, biotherapeutics, and other industries, today announced a collaboration with SinuSys Corporation

• Pressure BioSciences PCT Platform at Forefront in Generating Pivotal Findings by Diverse COVID-19 Research Teams in USA, China, and Europe

  12/17/2020

  PCT's Effectiveness and Reproducibility Impacts Research Results and Fills Critical Role in Achieving Important Insights for the Development of New and Improved COVID-19 Diagnostics and Therapeutics   [17-December-2020]   SOUTH EASTON, Mass. , Dec. 17, 2020 /PRNewswire/ -- Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" or the "Company"), a leader in the development and s

• Pressure BioSciences to Present at Upcoming Life Sciences Investor Forum

  12/15/2020

  Company Invites Individual and Institutional Investors, as well as Advisors and Analysts, to Attend Live, Interactive Presentations on Thursday, December 17, 2020

• Pressure BioSciences Proposed Acquisition Partner Cannaworx, Inc. Announces December 2020 Launch Date for FDA Registered Immune Booster

  12/4/2020

  Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" or the "Company"), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and platform technology solutions to the worldwide biotechnology, biotherapeutics, cosmeceuticals, nutraceuticals, and food & beverage industries, today announced that its proposed acquisition partner Cannaworx, Inc. has set December 2020

• Pressure BioSciences, Inc. Reports Third Quarter 2020 Financial Results and Provides Business Update

  11/17/2020

  Instrument Sales Increase 68%, Total Revenue Increases 7%, Operating Loss Decreases 23% (Q/Q); Planned Release of Revolutionary UST System in Mid-2021 Expected to Drive Major Revenue Growth and Progression to Profitability Investor Conference Call Scheduled for Tuesday, November 17, 2020 at 4:30 PM EST

• Pressure BioSciences, Inc. to Discuss Third Quarter 2020 Financial Results and Provide Business Update

  11/16/2020

  Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" and the "Company") today announced that the Company will host a teleconference to discuss its Third Quarter 2020 financial results and to provide a business update

• Pressure BioSciences Awarded First U.S. Patent for Revolutionary Ultra Shear Technology Platform

  11/11/2020

  Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" or the "Company"), today announced the award of the first U.S. patent for its revolutionary Ultra Shear Technology™ (UST™) platform entitled "System for High Pressure, High Shear Processing of Fluids.

• Pressure BioSciences Achieves Critical Milestone in Revolutionary Nanoemulsification Technology Development; Enters Production Era for Commercial System Development

  10/6/2020

  Company Locks-in Final Design Specifications, Begins Initial Build of Proprietary Ultra Shear Technology System, & Remains on Target for Commercial Release by Early 2021   [06-October-2020]   SOUTH EASTON, Mass. , Oct. 6, 2020 /PRNewswire/ -- Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" or the "Company"), a leader in the development and sale of broadly enabling, pr

• Pressure BioSciences Awarded Pivotal U.S. Patent for Novel, High Pressure Enhanced Consumable Device

  8/12/2020

   Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" or the "Company"), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables,

• Pressure BioSciences First Quarter 2020 Financial and Business Update to Include Jim Morrison, In-Coming CEO for Merged Companies of Availa Bio

  7/7/2020

  Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" and the "Company") today announced that the Company will host a teleconference to discuss its First Quarter 2020 financial results and to provide a business update,

• Pressure BioSciences and Leica Microsystems Sign Worldwide Co-Marketing Alliance: The Power of Laser Microdissection, PBI's PCT Platform, and Mass Spectrometry Results in Next Generation Analysis of Tumor Biopsy Tissues

  6/30/2020

  Unique Combination of Proprietary Technologies for Innovative Tumor Processing Workflow Expected to Accelerate Cancer R&D with Expanded IDs of Critical Disease State Biomarkers with Higher Precision and Speed

• $3,500,000 Initial Order for FDA-Registered, Premium Hand Sanitizer Catapults SkinScience Labs, a Pending Accretive Acquisition of Pressure BioSciences, Into the Multi-Billion Dollar Hand Sanitizer Market

  6/11/2020

  SkinScience Labs, Creator of Award-Winning Dr. Denese Skin Care & Anti-Aging Product Lines, Enters Hand Sanitizer Market with Proprietary Formula Developed by Founder Adrienne Denese, MD., Ph.D.

• Pressure BioSciences Announces First Manufacturing Build Completely Sold Out for Revolutionary UST System for Processing Hemp-Derived Cannabinoid Oil into Stable, Water-Soluble Nanoemulsions

  6/4/2020

  Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" or the "Company"), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and platform technology solu

• Pressure BioSciences Announces Launch of Novel, FDA Registered Immune Booster by Pending Merger Partner Cannaworx, Inc.

  5/28/2020

  Patented and Proprietary, the Company's Immune Booster is One of Very Few Hemp-Enhanced, FDA Registered Products with a Claim for Boosting the Immune System's Effectiveness Against Invading Pathogens